These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 9916663)

  • 1. Correlation of ambulatory 24-hour esophageal pH monitoring results with symptom improvement in patients with noncardiac chest pain due to gastroesophageal reflux disease.
    Fass R; Fennerty MB; Johnson C; Camargo L; Sampliner RE
    J Clin Gastroenterol; 1999 Jan; 28(1):36-9. PubMed ID: 9916663
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Diagnosis of gastroesophageal reflux disease-related noncardiac chest pain].
    Zheng J; Du ZM; Chen MH; Lin JK; Hu PJ
    Zhonghua Yi Xue Za Zhi; 2008 May; 88(20):1390-3. PubMed ID: 18953876
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Short course of omeprazole: a better first diagnostic approach to noncardiac chest pain than endoscopy, manometry, or 24-hour esophageal pH monitoring.
    Pandak WM; Arezo S; Everett S; Jesse R; DeCosta G; Crofts T; Gennings C; Siuta M; Zfass A
    J Clin Gastroenterol; 2002 Oct; 35(4):307-14. PubMed ID: 12352293
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of symptom index in identifying gastroesophageal reflux disease-related noncardiac chest pain.
    Dekel R; Martinez-Hawthorne SD; Guillen RJ; Fass R
    J Clin Gastroenterol; 2004 Jan; 38(1):24-9. PubMed ID: 14679323
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Abnormal GERD parameters on ambulatory pH monitoring predict therapeutic success in noncardiac chest pain.
    Kushnir VM; Sayuk GS; Gyawali CP
    Am J Gastroenterol; 2010 May; 105(5):1032-8. PubMed ID: 19920808
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Twenty-four-hour esophageal pH monitoring: the most useful test for evaluating noncardiac chest pain.
    Hewson EG; Sinclair JW; Dalton CB; Richter JE
    Am J Med; 1991 May; 90(5):576-83. PubMed ID: 2029015
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [What is the utility of proton pump inhibitor testing in non-cardiac chest pain?].
    Huamán JW; Aliaga V; Domenech G; Videla S; Saperas E
    Gastroenterol Hepatol; 2014 Oct; 37(8):452-61. PubMed ID: 24725608
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessment of clinical severity and investigation of uncomplicated gastroesophageal reflux disease and noncardiac angina-like chest pain.
    Lemire S
    Can J Gastroenterol; 1997 Sep; 11 Suppl B():37B-40B. PubMed ID: 9347176
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Asthma and gastroesophageal reflux: acid suppressive therapy improves asthma outcome.
    Harding SM; Richter JE; Guzzo MR; Schan CA; Alexander RW; Bradley LA
    Am J Med; 1996 Apr; 100(4):395-405. PubMed ID: 8610725
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prolonged ambulatory pH monitoring in patients with persistent gastroesophageal reflux disease symptoms: testing while on therapy identifies the need for more aggressive anti-reflux therapy.
    Katzka DA; Paoletti V; Leite L; Castell DO
    Am J Gastroenterol; 1996 Oct; 91(10):2110-3. PubMed ID: 8855731
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The cost-effectiveness of the omeprazole test in patients with noncardiac chest pain.
    Ofman JJ; Gralnek IM; Udani J; Fennerty MB; Fass R
    Am J Med; 1999 Sep; 107(3):219-27. PubMed ID: 10492314
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The clinical and economic value of a short course of omeprazole in patients with noncardiac chest pain.
    Fass R; Fennerty MB; Ofman JJ; Gralnek IM; Johnson C; Camargo E; Sampliner RE
    Gastroenterology; 1998 Jul; 115(1):42-9. PubMed ID: 9649457
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Noncardiac chest pain.
    Botoman VA
    J Clin Gastroenterol; 2002 Jan; 34(1):6-14. PubMed ID: 11743240
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Noncardiac chest pain: diagnosis and management.
    Yamasaki T; Fass R
    Curr Opin Gastroenterol; 2017 Jul; 33(4):293-300. PubMed ID: 28463855
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of one-week and two-week empirical trial with a high-dose rabeprazole in non-cardiac chest pain patients.
    Kim JH; Sinn DH; Son HJ; Kim JJ; Rhee JC; Rhee PL
    J Gastroenterol Hepatol; 2009 Sep; 24(9):1504-9. PubMed ID: 19467139
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Noncardiac chest pain: update on the diagnosis and management.
    Min YW; Rhee PL
    Korean J Gastroenterol; 2015 Feb; 65(2):76-84. PubMed ID: 25716709
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multimodality evaluation of patients with gastroesophageal reflux disease symptoms who have failed empiric proton pump inhibitor therapy.
    Galindo G; Vassalle J; Marcus SN; Triadafilopoulos G
    Dis Esophagus; 2013 Jul; 26(5):443-50. PubMed ID: 22862422
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Causes of non-cardiac chest pain: multidisciplinary perspective].
    Ortiz-Olvera NX; González-Martínez M; Ruiz-Flores LG; Blancas-Valencia JM; Morán-Villota S; Dehesa-Violante M
    Rev Gastroenterol Mex; 2007; 72(2):92-9. PubMed ID: 17966367
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Approach to the patient with unexplained chest pain.
    Katz PO
    Semin Gastrointest Dis; 2001 Jan; 12(1):38-45. PubMed ID: 11216468
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinically distinct characteristics in patients younger than 40 years old with non-cardiac chest pain.
    Ko SY; Kim SI; Kim JH; Lee JH; Lee KJ; Hong SN; Lee SY; Sung IK; Park HS; Shim CS
    J Gastroenterol Hepatol; 2012 Sep; 27(9):1484-9. PubMed ID: 22554344
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.